weight maintenance program*medical care setting*comprehensive weight maintenance*total meal replacement*baseline body weight*maintenance counseling*weight maintenance counseling*loss such program*comprehensive weight loss*weight loss maintenance*loss sustained weight*diet physical activity*intensive behavioral lifestyle*loss maintenance program*behavioral lifestyle*body weight weekly*necessary energy deficit*least monthly contact*close medical monitoring*behavioral lifestyle intervention*short term weight
weight loss treatment*comprehensive weight management*metabolic surgery*nonsurgical subject*lifelong lifestyle support*optimal medical therapy
aglucosidase*diet physical activity*glucose lowering medication*insufficient weight loss*alpha glucosidase*diabetes provider*aglucosidase inhibitor*weight loss medication
lower gfr range*filtration rate gfr*min week minimum*goal metformin*longstanding evidence base*min week*physical activity goal*goal metformin monotherapy*glycemic goal metformin*ml min*gfr range
loss ketosis*ongoing glycemia reduction*inhibitor glp1 analog*inhibitor glp1*sulfonylurea dpp4*dpp4 inhibitor glp1*comparative effectiveness study*moderate glycemic effect*catabolic feature weight*study grade*glp1 analog*secretagogues meglitinides*feature weight loss*late postprandial hypoglycemia*class sulfonylurea dpp4*effectiveness study grade*health economic outcome*weight loss ketosis*ongoing glycemia*class sulfonylurea*catabolic feature*glycemia reduction*irregular meal schedule*medical psychosocial*drug class sulfonylurea*glycemia reduction approach*major drug class*sulfonylurea dpp4 inhibitor
noninsulin agent*inhibitor glp1*sulfonylurea dpp4*acceptable fasting*concentrated preparation*dpp4 inhibitor glp1*glycemic goal provider*initiate insulin therapy*limited dosing range*glp1 receptor agonist*combination injectable therapy*serial lung function*insulin analog people*complex insulin regimen*postprandial glucose excursion*u300 glargine*suboptimal blood glucose*acceptable fasting blood*regimen flexibility*complex insulin*dos adjunctive use*analog people*limited dosing*prandial use*basal insulin analog*bolus insulin dosing*serial lung*u200 degludec*goal provider*lung function testing*sulfonylurea dpp4 inhibitor
min week
